Literature DB >> 7990448

Drugs-of-abuse testing in urine: statistical approach and experimental comparison of immunochemical and chromatographic techniques.

S D Ferrara1, L Tedeschi, G Frison, G Brusini, F Castagna, B Bernardelli, D Soregaroli.   

Abstract

This study deals with the experimental and statistical comparison of six immunochemical techniques, including noninstrumental on-site and instrumental formats (EIA-EMIT and EZ-SCREEN; FPIA-ADx; RIA-Coat-A-Count; LI-Abuscreen ONTRAK; CBI-Triage), and three chromatographic techniques (TLC-Toxi-Lab; HPLC; HPLC-REMEDi drug profiling system), using GC-MS as a reference technique for analyzing amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine, methadone, and opiates in the urine of various kinds of drug users. The study reports (a) the values of sensitivity, specificity, false-positive rates, and false-negative rates of each technique; (b) the results of bayesian statistical analysis, which are based on prevalence values of the samples examined and expressed as positive and negative predictive values and cumulative predictive values for each single technique and for combinations of paired immunochemical and chromatographic techniques; and (c) the results of a rough classification of the various degrees of predictability of these techniques. Lastly, this study proposes a decision-making process for establishing the best combination of analytical techniques for the goals in question, according to the characteristics and facilities of each laboratory.

Mesh:

Substances:

Year:  1994        PMID: 7990448     DOI: 10.1093/jat/18.5.278

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

1.  Importance of Urinary Drug Screening in the Multiple Sleep Latency Test and Maintenance of Wakefulness Test.

Authors:  Angela M Anniss; Alan Young; Denise M O'Driscoll
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

2.  Sample purification procedure for confirmation of 3'-hydroxy stanozolol by gas chromatography/high resolution mass spectrometry.

Authors:  S Ahi; I M Reddy; A Beotra; R Lal; S Jain; T Kaur
Journal:  Indian J Pharmacol       Date:  2008-08       Impact factor: 1.200

3.  Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids.

Authors:  Jon Andsnes Berg; Jan Schjøtt; Kjell O Fossan; Bettina Riedel
Journal:  Subst Abuse Rehabil       Date:  2015-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.